Six Microsatellite Markers on the Short Arm of Chromosome 6 in Relation to HLA-DR3 and TNF−308A in Systemic Lupus Erythematosus

Total Page:16

File Type:pdf, Size:1020Kb

Six Microsatellite Markers on the Short Arm of Chromosome 6 in Relation to HLA-DR3 and TNF−308A in Systemic Lupus Erythematosus Genes and Immunity (2001) 2, 373–380 2001 Nature Publishing Group All rights reserved 1466-4879/01 $15.00 www.nature.com/gene Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF−308A in systemic lupus erythematosus MW van der Linden1,2, AR van der Slik3, E Zanelli3, MJ Giphart3, E Pieterman2, GMTh Schreuder3, RGJ Westendorp4 and TWJ Huizinga2 Departments of 1Clinical Epidemiology, 2Rheumatology, 3Immunohaematology and Blood Transfusion, 4General Internal Medicine, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands Differences in allelic distribution at loci surrounding the human HLA-DRB1 and tumor necrosis factor (TNF) genes have been observed in association with systemic lupus erythematosus (SLE). We investigated whether the association of HLA- DRB1*0301 (HLA-DR3) and TNF−308A with SLE could be attributed to polymorphic markers in the chromosomal region encompassed by HLA-DRB1 and HLA-C. Ninety-one consecutive Caucasian patients with SLE and 253 controls (organ donors) were typed for HLA-DRB1, microsatellites D6S1014, D6S273, TNFa, MIB, C1F2F5, and C1F3F2 and the single nucleotide polymorphism at position −308 in the promoter of TNF. The independent contribution of alleles to disease susceptibility was estimated by cross-tabulation and multivariate logistic regression. Possession of TNF−308A was associated with susceptibility to SLE (odds ratio [95% confidence interval], 3.70 [2.24–6.11]). This remained present after stratification on possession of HLA-DR3 (pooled odds ratio, 2.53 [1.37–4.70]). Stratification revealed a possible association of possession of C1F2F5*192 with protection from SLE beyond the effects of HLA-DR3 and TNF−308A. A gene dosage effect was observed for −308A only (homozygotes, 7.75 [3.01–20.0], heterozygotes, 3.15 [1.85–5.37]). In multivariate analysis, possession of HLA-DR3, TNF−308A, and C1F2F5*192 remained independently associated with susceptibility to SLE (2.58 [1.29–5.18], 2.76 [1.43–5.31], and 0.26 [0.10–0.66], respectively). The association of possession of TNF−308A with susceptibility to SLE cannot be attributed to linkage to HLA-DR3 alone, nor to other polymorphic markers in the vicinity of the TNF gene. Further loci that are independently associated with SLE might be in the vicinity of marker C1F2F5. Genes and Immunity (2001) 2, 373–380. Keywords: HLA-DRB1; TNF; genetics; susceptibility; systemic lupus erythematosus Introduction be associated with susceptibility to SLE among African- Americans.12 Estimates of the allele frequency of the The chromosomal region encompassing the human leu- allele TNF−308A range from 17% to 28% in different Cau- kocyte antigen (HLA) Class II to Class I genes has been casian control populations.8,13–17 In our study among Eur- implicated in susceptibility to systemic lupus ery- opean Caucasians, the association between possession of thematosus (SLE) and other autoimmune diseases, such TNF−308A and SLE was independent of the existing as rheumatoid arthritis, insulin-dependent diabetes mel- association between possession of the HLA-DRB1*0301 litus, atopic astma, multiple sclerosis, and Crohn’s dis- (HLA-DR3) allele and SLE, in spite of linkage disequilib- 1–7 ease. Alleles of the HLA-Class II gene, HLA-DRB1, are rium between alleles of these loci.18 in linkage disequilibrium with genetic variations in the This previously detected association between presence 8,9 tumor necrosis factor (TNF) gene. of a TNF−308A allele and susceptibility to SLE might be Involvement of TNF in SLE was suggested by animal attributed to genetic variations in the region surrounding models, in which development of glomerulonephritis the TNF locus, apart from HLA-DR3. To investigate this 10 was delayed upon administration of recombinant TNF. possibility, we typed six microsatellite loci in a 1.8 million Disease activity in patients with SLE correlates with the base-pair region encompassed by HLA-DRB1 and HLA- 11 levels of circulating TNF. Recently, possession of the C in patients with SLE and controls. rare allele of a single nucleotide polymorphism located − at 308 base pairs from the transcription initiation site in Results the promoter of TNF (TNF2, TNF−308A), was shown to Demographic characteristics The mean age of the patients was similar to that of the Correspondence: Dr TWJ Huizinga, Department of Rheumatology, Build- controls (39.6 ± 1.5 vs 38.6 ± 1.1 years, mean ± standard ing 1, C4-R, Leiden University Medical Center, P.O. Box 9600, 2300 RC error). The patients were more often female than the con- Leiden, The Netherlands. E-mail: T.W.J.Huizinga.reumaȰlumc.nl MW van der Linden is supported by a grant of the Dutch Organiza- trols (92% and 46% females, respectively), but this did tion for Scientific Research (N.W.O.), grant no. 904–61–110. not influence genotype distributions among patients Received 8 February 2001; revised and accepted 6 August 2001 and controls. Microsatellite markers in SLE MW van der Linden et al 374 Allelic distribution of polymorphic markers contribution of each risk factor and thus to adjust for the Homozygosity of polymorphic markers was largest for effect of linkage disequilibrium, a stratified analysis was C1F3F2 with 39% in patients and 40% in controls and undertaken. The risk to develop SLE in the presence of lowest in MIB, with 15% and 11%. Four percent of all candidate alleles was studied in the presence and in the subjects were homozygous for HLA-DR3 (7% in patients, absence of HLA-DR3 separately. In Table 2 these odds 3% in controls) and 6% were homozygous for TNF−308A ratios are depicted separately for the HLA-DR3-positive (14% in the patients, 3% in the controls). and DR3-negative strata. To summarize the effect of each Individual alleles were studied. The relative risk to allele in both strata combined, the weighed estimate of develop disease, conferred by an extremely rare allele, the stratum-specificoddsratiosisgiven(Mantel–Haenszel may be larger than the relative risk conferred by a com- odds ratio). This pooled odds ratio is an estimate of the mon allele, merely as a consequence of small numbers. effect of each allele on susceptibility to (or protection from) To prevent the low background frequency of certain SLE, adjusted for its distribution over HLA-DR3-positive alleles from introducing spurious associations, the con- persons and HLA-DR3-negative persons. clusions were restricted to the effects of either relatively By this analysis of effects across the separate strata, the common alleles (more than 20% frequency of persons consequences of linkage disequilibrium between studied possessing at least of these alleles), or alleles with a clear alleles and HLA-DR3 became apparent. The odds ratios and distinctive impact on disease risk (unadjusted odds for presence of the alleles D6S1014*134 and MIB*350 ratio or unadjusted odds ratio−1 of 2.5 or greater). Also, became nonsignificant. This indicates that the effect of alleles that are bound to have such an impact merely on risk to develop SLE in the presence of these alleles is the basis of their low frequency, below 5%, are excluded. dependent on possession of HLA-DR3. For D6S273*139 Frequencies of persons possessing these 22 selected and TNFa*99, the stratum-specific odds ratios appeared alleles are depicted in Table 1, with odds ratios rep- to indicate opposite effects among HLA-DR3-positive resenting the risk to develop SLE among persons with and HLA-DR3-negative persons (test indicating hetero- the allele compared with that among persons without the geneity: P = 0.004 and P = 0.049, respectively). Therefore, allele. Frequencies of the presence of 10 alleles were sig- the pooled odds ratio is inconclusive for D6S237*139 and nificantly different among the patients compared with TNFa*99. Possession of the alleles D6S1014*143, controls (eight alleles present in increased frequencies, TNF−308A, C1F2F5*196 and C1F3F2*354 appeared to be two alleles present in decreased frequency). statistically significantly associated with susceptibility to SLE, independent of possession of HLA-DR3. The effect Stratified analysis was present and concordant in HLA-DR3-positives and Confounder effects arise, for example due to linkage dis- HLA-DR3-negatives. Possession of C1F2F5*192 appeared equilibrium with HLA-DR3. To estimate the individual protective, independent of possession of HLA-DR3. Table 1 Frequencies of selected polymorphic marker alleles in patients with systemic lupus erythematosus and controls Locus Allelea Patients (n = 91) Controls (n = 253) Odds ratiob (95% confidence interval) n (%) n (%) HLA-DR 3 45 (49) 57 (23) 3.36 (2.03–5.58)* D6S1014 134 28 (31) 113 (45) 0.55 (0.33–0.92)* 137 63 (69) 178 (70) 0.95 (0.56–1.60) 143 42 (46) 47 (19) 3.76 (2.23–6.32)* D6S273 131 26 (29) 60 (24) 1.29 (0.75–2.21) 133 37 (41) 131 (52) 0.64 (0.39–1.04) 135 43 (47) 140 (55) 0.72 (0.45–1.17) 139 27 (29) 45 (18) 1.95 (1.12–3.39)* TNF −308 A 52 (57) 67 (26) 3.70 (2.24–6.11)* TNFa 99 56 (65) 125 (49) 1.64 (1.01–2.67)* 107 20 (22) 71 (28) 0.72 (0.41–1.27) 115 17 (19) 53 (21) 0.87 (0.47–1.59) 117 29 (32) 78 (31) 1.05 (0.57–1.55) MIB 326 17 (19) 61 (24) 0.72 (0.40–1.32) 336 31 (34) 90 (36) 0.94 (0.57–1.55) 350 49 (54) 81 (32) 2.48 (1.52–4.04)* C1F2F5 192 6 (7) 41 (16) 0.37 (0.15–0.89)* 196 41 (45) 55 (22) 2.95 (1.77–4.91)* 199 28 (31) 94 (37) 0.75 (0.45–1.26) C1F3F2 342 33 (36) 100 (40) 0.87 (0.53–1.43) 354 54 (59) 95 (38) 2.43 (1.49–3.96)* 360 23 (25) 82 (32) 0.71 (0.41–1.21) aAlleles defined by fragment size (in base pairs), except HLA-DR3 and TNF-308A.
Recommended publications
  • LST1 Sirna (M): Sc-149136
    SANTA CRUZ BIOTECHNOLOGY, INC. LST1 siRNA (m): sc-149136 BACKGROUND APPLICATIONS LST1 (leukocyte-specific transcript 1), also known as B144, is a 97 amino acid LST1 siRNA (m) is recommended for the inhibition of LST1 expression in protein single-pass membrane protein. LST1 may play a role in modulating mouse cells. immune responses, as well as dendritic cell maturation. LST1 has also been found to induce morphological changes, including microspikes and filopodia, SUPPORT REAGENTS when overexpressed in a variety of cell types. Localized to the endomembrane For optimal siRNA transfection efficiency, Santa Cruz Biotechnology’s system, LST1 is expressed as nine isoforms produced by alternative splicing. siRNA Transfection Reagent: sc-29528 (0.3 ml), siRNA Transfection Medium: Isoform 1, also designated LST1A, and isoform 2, also designated LST1C, sc-36868 (20 ml) and siRNA Dilution Buffer: sc-29527 (1.5 ml) are recom- γ have inhibitory effects on lymphocyte proliferation. Induced by IFN- , LST1 mended. Control siRNAs or Fluorescein Conjugated Control siRNAs are is expressed in adult lung, thymus, placenta, kidney and tonsil and fetal liver, available as 10 µM in 66 µl. Each contain a scrambled sequence that will spleen and brain. not lead to the specific degradation of any known cellular mRNA. Fluorescein Conjugated Control siRNAs include: sc-36869, sc-44239, sc-44240 and REFERENCES sc-44241. Control siRNAs include: sc-37007, sc-44230, sc-44231, sc-44232, 1. Neville, M.J. and Campbell, R.D. 1997. Alternative splicing of the LST1 gene sc-44233, sc-44234, sc-44235, sc-44236, sc-44237 and sc-44238. located in the major histocompatibility complex on human chromosome 6.
    [Show full text]
  • Genetic Variation of Genes for Xenobiotic-Metabolizing
    Journal of Human Genetics (2009) 54, 440–449 & 2009 The Japan Society of Human Genetics All rights reserved 1434-5161/09 $32.00 www.nature.com/jhg ORIGINAL ARTICLE Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene–gene and gene–environment interactions for disease susceptibility Alexey V Polonikov, Vladimir P Ivanov and Maria A Solodilova The aim of our pilot study was to evaluate the contribution of genes for xenobiotic-metabolizing enzymes (XMEs) for the development of bronchial asthma. We have genotyped 25 polymorphic variants of 18 key XME genes in 429 Russians, including 215 asthmatics and 214 healthy controls by a polymerase chain reaction, followed by restriction fragment length polymorphism analyses. We found for the first time significant associations of CYP1B1 V432L (P¼0.045), PON1 Q192R (P¼0.039) and UGT1A6 T181A (P¼0.025) gene polymorphisms with asthma susceptibility. Significant P-values were evaluated through Monte-Carlo simulations. The multifactor-dimensionality reduction method has obtained the best three-locus model for gene–gene interactions between three loci, EPHX1 Y113H, CYP1B1 V432L and CYP2D6 G1934A, in asthma at a maximum cross-validation consistency of 100% (P¼0.05) and a minimum prediction error of 37.8%. We revealed statistically significant gene–environment interactions (XME genotypes–smoking interactions) responsible for asthma susceptibility for seven XME genes. A specific pattern of gametic correlations between alleles of XME genes was found in asthmatics in comparison with healthy individuals. The study results point to the potential relevance of toxicogenomic mechanisms of bronchial asthma in the modern world, and may thereby provide a novel direction in the genetic research of the respiratory disease in the future.
    [Show full text]
  • Role of RUNX1 in Aberrant Retinal Angiogenesis Jonathan D
    Page 1 of 25 Diabetes Identification of RUNX1 as a mediator of aberrant retinal angiogenesis Short Title: Role of RUNX1 in aberrant retinal angiogenesis Jonathan D. Lam,†1 Daniel J. Oh,†1 Lindsay L. Wong,1 Dhanesh Amarnani,1 Cindy Park- Windhol,1 Angie V. Sanchez,1 Jonathan Cardona-Velez,1,2 Declan McGuone,3 Anat O. Stemmer- Rachamimov,3 Dean Eliott,4 Diane R. Bielenberg,5 Tave van Zyl,4 Lishuang Shen,1 Xiaowu Gai,6 Patricia A. D’Amore*,1,7 Leo A. Kim*,1,4 Joseph F. Arboleda-Velasquez*1 Author affiliations: 1Schepens Eye Research Institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, 20 Staniford St., Boston, MA 02114 2Universidad Pontificia Bolivariana, Medellin, Colombia, #68- a, Cq. 1 #68305, Medellín, Antioquia, Colombia 3C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114 4Retina Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 243 Charles St., Boston, MA 02114 5Vascular Biology Program, Boston Children’s Hospital, Department of Surgery, Harvard Medical School, 300 Longwood Ave., Boston, MA 02115 6Center for Personalized Medicine, Children’s Hospital Los Angeles, Los Angeles, 4650 Sunset Blvd, Los Angeles, CA 90027, USA 7Department of Pathology, Harvard Medical School, 25 Shattuck St., Boston, MA 02115 Corresponding authors: Joseph F. Arboleda-Velasquez: [email protected] Ph: (617) 912-2517 Leo Kim: [email protected] Ph: (617) 912-2562 Patricia D’Amore: [email protected] Ph: (617) 912-2559 Fax: (617) 912-0128 20 Staniford St. Boston MA, 02114 † These authors contributed equally to this manuscript Word Count: 1905 Tables and Figures: 4 Diabetes Publish Ahead of Print, published online April 11, 2017 Diabetes Page 2 of 25 Abstract Proliferative diabetic retinopathy (PDR) is a common cause of blindness in the developed world’s working adult population, and affects those with type 1 and type 2 diabetes mellitus.
    [Show full text]
  • Pharmacogenetics: a Tool for Identifying Genetic Factors in Drug Dependence and Response to Treatment
    RESEARCH REVIEW—PHARMACOGENETICS • 17 Pharmacogenetics: A Tool for Identifying Genetic Factors in Drug Dependence and Response to Treatment harmacogenetics research looks at variations in the human genome and ways in which genetic factors might influence Phow individuals respond to drugs. The authors review basic principles of pharmacogenetics and cite findings from several gene-phenotype studies to illustrate possible associations between genetic variants, drug-related behaviors, and risk for drug dependence. Some gene variants affect responses to one drug; others, to various drugs. Pharmacogenetics can inform medica- tion development and personalized treatment strategies; challenges lie along the pathway to its general use in clinical practice. Margaret Mroziewicz, M.Sc.1 ubstance dependence is a complex psychiatric disorder that develops in Rachel F. Tyndale, Ph.D. 1,2,3 response to a combination of environmental and genetic risk factors and 1 Department of Pharmacology and Toxicology drug-induced effects (Ho et al., 2010). The strong genetic basis of depen- University of Toronto S Toronto, Canada dence is supported by family, adoption, and twin studies, which demonstrate 2Department of Psychiatry substantial heritability, estimated to be about 50 percent (Uhl et al., 2008). The University of Toronto Toronto, Canada evidence suggests that no single variant accounts for a major portion of this risk, 3Centre for Addiction and Mental Health but that variations in many genes each contribute a small amount. Toronto, Canada Pharmacogenetics is the study of the genetic factors that influence drug response and toxicity. In this review, we briefly state the basic principles of pharmacoge- netics and then provide examples of discoveries that demonstrate the impact of genetic variation on drug dependence, drug effects, and drug-induced behaviors.
    [Show full text]
  • Transposon Variants and Their Effects on Gene Expression in Arabidopsis
    Transposon Variants and Their Effects on Gene Expression in Arabidopsis Xi Wang, Detlef Weigel*, Lisa M. Smith* Department of Molecular Biology, Max Planck Institute for Developmental Biology, Tu¨bingen, Germany Abstract Transposable elements (TEs) make up the majority of many plant genomes. Their transcription and transposition is controlled through siRNAs and epigenetic marks including DNA methylation. To dissect the interplay of siRNA–mediated regulation and TE evolution, and to examine how TE differences affect nearby gene expression, we investigated genome- wide differences in TEs, siRNAs, and gene expression among three Arabidopsis thaliana accessions. Both TE sequence polymorphisms and presence of linked TEs are positively correlated with intraspecific variation in gene expression. The expression of genes within 2 kb of conserved TEs is more stable than that of genes next to variant TEs harboring sequence polymorphisms. Polymorphism levels of TEs and closely linked adjacent genes are positively correlated as well. We also investigated the distribution of 24-nt-long siRNAs, which mediate TE repression. TEs targeted by uniquely mapping siRNAs are on average farther from coding genes, apparently because they more strongly suppress expression of adjacent genes. Furthermore, siRNAs, and especially uniquely mapping siRNAs, are enriched in TE regions missing in other accessions. Thus, targeting by uniquely mapping siRNAs appears to promote sequence deletions in TEs. Overall, our work indicates that siRNA–targeting of TEs may influence removal of sequences from the genome and hence evolution of gene expression in plants. Citation: Wang X, Weigel D, Smith LM (2013) Transposon Variants and Their Effects on Gene Expression in Arabidopsis. PLoS Genet 9(2): e1003255.
    [Show full text]
  • Essential Trace Elements in Human Health: a Physician's View
    Margarita G. Skalnaya, Anatoly V. Skalny ESSENTIAL TRACE ELEMENTS IN HUMAN HEALTH: A PHYSICIAN'S VIEW Reviewers: Philippe Collery, M.D., Ph.D. Ivan V. Radysh, M.D., Ph.D., D.Sc. Tomsk Publishing House of Tomsk State University 2018 2 Essential trace elements in human health UDK 612:577.1 LBC 52.57 S66 Skalnaya Margarita G., Skalny Anatoly V. S66 Essential trace elements in human health: a physician's view. – Tomsk : Publishing House of Tomsk State University, 2018. – 224 p. ISBN 978-5-94621-683-8 Disturbances in trace element homeostasis may result in the development of pathologic states and diseases. The most characteristic patterns of a modern human being are deficiency of essential and excess of toxic trace elements. Such a deficiency frequently occurs due to insufficient trace element content in diets or increased requirements of an organism. All these changes of trace element homeostasis form an individual trace element portrait of a person. Consequently, impaired balance of every trace element should be analyzed in the view of other patterns of trace element portrait. Only personalized approach to diagnosis can meet these requirements and result in successful treatment. Effective management and timely diagnosis of trace element deficiency and toxicity may occur only in the case of adequate assessment of trace element status of every individual based on recent data on trace element metabolism. Therefore, the most recent basic data on participation of essential trace elements in physiological processes, metabolism, routes and volumes of entering to the body, relation to various diseases, medical applications with a special focus on iron (Fe), copper (Cu), manganese (Mn), zinc (Zn), selenium (Se), iodine (I), cobalt (Co), chromium, and molybdenum (Mo) are reviewed.
    [Show full text]
  • Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
    pharmaceuticals Review Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters Teresa Iannaccone 1, Carmine Sellitto 1,2,* , Valentina Manzo 1,2 , Francesca Colucci 1, Valentina Giudice 1 , Berenice Stefanelli 1 , Antonio Iuliano 1, Giulio Corrivetti 3 and Amelia Filippelli 1,2 1 Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, 84081 Baronissi, Italy; [email protected] (T.I.); [email protected] (V.M.); [email protected] (F.C.); [email protected] (V.G.); [email protected] (B.S.); [email protected] (A.I.); afi[email protected] (A.F.) 2 Clinical Pharmacology and Pharmacogenetics Unit, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, 84131 Salerno, Italy 3 European Biomedical Research Institute of Salerno (EBRIS), 84125 Salerno, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-089673848 Abstract: Pharmacogenomics can identify polymorphisms in genes involved in drug pharma- cokinetics and pharmacodynamics determining differences in efficacy and safety and causing inter-individual variability in drug response. Therefore, pharmacogenomics can help clinicians in optimizing therapy based on patient’s genotype, also in psychiatric and neurological settings. Citation: Iannaccone, T.; Sellitto, C.; However, pharmacogenetic screenings for psychotropic drugs are not routinely employed in diagno- Manzo, V.; Colucci, F.; Giudice, V.; Stefanelli, B.; Iuliano, A.; Corrivetti, sis and monitoring of patients treated with mood stabilizers, such as carbamazepine and valproate, G.; Filippelli, A. Pharmacogenetics of because their benefit in clinical practice is still controversial. In this review, we summarize the current Carbamazepine and Valproate: Focus knowledge on pharmacogenetic biomarkers of these anticonvulsant drugs.
    [Show full text]
  • B Inhibition in a Mouse Model of Chronic Colitis1
    The Journal of Immunology Differential Expression of Inflammatory and Fibrogenic Genes and Their Regulation by NF-␬B Inhibition in a Mouse Model of Chronic Colitis1 Feng Wu and Shukti Chakravarti2 Fibrosis is a major complication of chronic inflammation, as seen in Crohn’s disease and ulcerative colitis, two forms of inflam- matory bowel diseases. To elucidate inflammatory signals that regulate fibrosis, we investigated gene expression changes under- lying chronic inflammation and fibrosis in trinitrobenzene sulfonic acid-induced murine colitis. Six weekly 2,4,6-trinitrobenzene sulfonic acid enemas were given to establish colitis and temporal gene expression patterns were obtained at 6-, 8-, 10-, and 12-wk time points. The 6-wk point, TNBS-w6, was the active, chronic inflammatory stage of the model marked by macrophage, neu- trophil, and CD3؉ and CD4؉ T cell infiltrates in the colon, consistent with the idea that this model is T cell immune response driven. Proinflammatory genes Cxcl1, Ccl2, Il1b, Lcn2, Pla2g2a, Saa3, S100a9, Nos2, Reg2, and Reg3g, and profibrogenic extra- cellular matrix genes Col1a1, Col1a2, Col3a1, and Lum (lumican), encoding a collagen-associated proteoglycan, were up-regulated at the active/chronic inflammatory stages. Rectal administration of the NF-␬B p65 antisense oligonucleotide reduced but did not abrogate inflammation and fibrosis completely. The antisense oligonucleotide treatment reduced total NF-␬B by 60% and down- regulated most proinflammatory genes. However, Ccl2, a proinflammatory chemokine known to promote fibrosis, was not down- regulated. Among extracellular matrix gene expressions Lum was suppressed while Col1a1 and Col3a1 were not. Thus, effective treatment of fibrosis in inflammatory bowel disease may require early and complete blockade of NF-␬B with particular attention to specific proinflammatory and profibrogenic genes that remain active at low levels of NF-␬B.
    [Show full text]
  • Pan-Cancer Analysis of DNA Methylation Identifies Genes And
    bioRxiv preprint doi: https://doi.org/10.1101/2021.06.20.449136; this version posted June 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Pan-Cancer Analysis of DNA Methylation Identifies Genes and Biological Functions Associated with Overall Survival Romola Cavet1, Peng Yue2, Guy Cavet*3 1The Nueva School, San Mateo, California, United States of America 2ReviR Therapeutics, Palo Alto, California, United States of America 3Paramune, Inc., Palo Alto, California, United States of America * Corresponding author E-Mail: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2021.06.20.449136; this version posted June 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Abstract DNA methylation influences gene expression and is altered in many cancers, but the relationship between DNA methylation and cancer outcomes is not yet fully understood. If methylation of specific genes is associated with better or worse outcomes, it could implicate genes in driving cancer and suggest therapeutic strategies. To advance our understanding of DNA methylation in cancer biology, we conducted a pan-cancer analysis of the relationship between methylation and overall survival. Using data on 28 tumor types from The Cancer Genome Atlas (TCGA), we identified genes and genomic regions whose methylation was recurrently associated with survival across multiple cancer types.
    [Show full text]
  • Idiopathic Infertility As a Feature of Genome Instability
    life Review Idiopathic Infertility as a Feature of Genome Instability Agrita Puzuka 1,2, Baiba Alksere 1,3, Linda Gailite 1 and Juris Erenpreiss 1,3,* 1 Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia; [email protected] (A.P.); [email protected] (B.A.); [email protected] (L.G.) 2 Department of Biology and Microbiology, Riga Stradins University, LV-1007 Riga, Latvia 3 EAA Andrology Centre, Clinic IVF-Riga, LV-1010 Riga, Latvia * Correspondence: [email protected] Abstract: Genome instability may play a role in severe cases of male infertility, with disrupted sper- matogenesis being just one manifestation of decreased general health and increased morbidity. Here, we review the data on the association of male infertility with genetic, epigenetic, and environmental alterations, the causes and consequences, and the methods for assessment of genome instability. Male infertility research has provided evidence that spermatogenic defects are often not limited to testicular dysfunction. An increased incidence of urogenital disorders and several types of cancer, as well as overall reduced health (manifested by decreased life expectancy and increased morbidity) have been reported in infertile men. The pathophysiological link between decreased life expectancy and male infertility supports the notion of male infertility being a systemic rather than an isolated condition. It is driven by the accumulation of DNA strand breaks and premature cellular senescence. We have presented extensive data supporting the notion that genome instability can lead to severe male infertility termed “idiopathic oligo-astheno-teratozoospermia.” We have detailed that genome instability in men with oligo-astheno-teratozoospermia (OAT) might depend on several genetic Citation: Puzuka, A.; Alksere, B.; and epigenetic factors such as chromosomal heterogeneity, aneuploidy, micronucleation, dynamic Gailite, L.; Erenpreiss, J.
    [Show full text]
  • Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection
    fgene-11-00358 April 9, 2020 Time: 15:55 # 1 ORIGINAL RESEARCH published: 15 April 2020 doi: 10.3389/fgene.2020.00358 Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection Allen F. Ryan1*, Chanond A. Nasamran2, Kwang Pak1, Clara Draf1, Kathleen M. Fisch2, Nicholas Webster3 and Arwa Kurabi1 1 Departments of Surgery/Otolaryngology, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States, 2 Medicine/Center for Computational Biology & Bioinformatics, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States, 3 Medicine/Endocrinology, UC San Diego School of Medicine, VA Medical Center, La Jolla, CA, United States Single-cell transcriptomics was used to profile cells of the normal murine middle ear. Clustering analysis of 6770 transcriptomes identified 17 cell clusters corresponding to distinct cell types: five epithelial, three stromal, three lymphocyte, two monocyte, Edited by: two endothelial, one pericyte and one melanocyte cluster. Within some clusters, Amélie Bonnefond, Institut National de la Santé et de la cell subtypes were identified. While many corresponded to those cell types known Recherche Médicale (INSERM), from prior studies, several novel types or subtypes were noted. The results indicate France unexpected cellular diversity within the resting middle ear mucosa. The resolution of Reviewed by: Fabien Delahaye, uncomplicated, acute, otitis media is too rapid for cognate immunity to play a major Institut Pasteur de Lille, France role. Thus innate immunity is likely responsible for normal recovery from middle ear Nelson L. S. Tang, infection. The need for rapid response to pathogens suggests that innate immune The Chinese University of Hong Kong, China genes may be constitutively expressed by middle ear cells.
    [Show full text]
  • ID AKI Vs Control Fold Change P Value Symbol Entrez Gene Name *In
    ID AKI vs control P value Symbol Entrez Gene Name *In case of multiple probesets per gene, one with the highest fold change was selected. Fold Change 208083_s_at 7.88 0.000932 ITGB6 integrin, beta 6 202376_at 6.12 0.000518 SERPINA3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 1553575_at 5.62 0.0033 MT-ND6 NADH dehydrogenase, subunit 6 (complex I) 212768_s_at 5.50 0.000896 OLFM4 olfactomedin 4 206157_at 5.26 0.00177 PTX3 pentraxin 3, long 212531_at 4.26 0.00405 LCN2 lipocalin 2 215646_s_at 4.13 0.00408 VCAN versican 202018_s_at 4.12 0.0318 LTF lactotransferrin 203021_at 4.05 0.0129 SLPI secretory leukocyte peptidase inhibitor 222486_s_at 4.03 0.000329 ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 1552439_s_at 3.82 0.000714 MEGF11 multiple EGF-like-domains 11 210602_s_at 3.74 0.000408 CDH6 cadherin 6, type 2, K-cadherin (fetal kidney) 229947_at 3.62 0.00843 PI15 peptidase inhibitor 15 204006_s_at 3.39 0.00241 FCGR3A Fc fragment of IgG, low affinity IIIa, receptor (CD16a) 202238_s_at 3.29 0.00492 NNMT nicotinamide N-methyltransferase 202917_s_at 3.20 0.00369 S100A8 S100 calcium binding protein A8 215223_s_at 3.17 0.000516 SOD2 superoxide dismutase 2, mitochondrial 204627_s_at 3.04 0.00619 ITGB3 integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) 223217_s_at 2.99 0.00397 NFKBIZ nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta 231067_s_at 2.97 0.00681 AKAP12 A kinase (PRKA) anchor protein 12 224917_at 2.94 0.00256 VMP1/ mir-21likely ortholog
    [Show full text]